ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
-0.30%
Brent Oil
81.295
0.00%
Bitcoin
67,762.46
0.42%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Icosavax Inc (ICVX)

  7. Icosavax Inc (ICVX) Noticias

ICVX

Icosavax (ICVX)

Icosavax Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ICVX
FechaHoraFuenteTítuloSímboloCompañía
01/03/202407:30Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ICVXIcosavax Inc
21/02/202415:21Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ICVXIcosavax Inc
20/02/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ICVXIcosavax Inc
20/02/202418:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICVXIcosavax Inc
20/02/202407:46Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ICVXIcosavax Inc
20/02/202407:43Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ICVXIcosavax Inc
20/02/202407:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICVXIcosavax Inc
20/02/202407:32Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ICVXIcosavax Inc
01/02/202413:25PR Newswire (US)Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law FirmNASDAQ:ICVXIcosavax Inc
12/01/202410:10PR Newswire (US)Kuehn Law Encourages PXD, IMGN, HA and ICVX Investors to Contact Law FirmNASDAQ:ICVXIcosavax Inc
04/01/202415:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ICVXIcosavax Inc
03/01/202413:57PR Newswire (US)Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law FirmNASDAQ:ICVXIcosavax Inc
27/12/202307:55Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:ICVXIcosavax Inc
20/12/202316:05Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:ICVXIcosavax Inc
12/12/202305:25Dow Jones NewsIcosavax Shares Take Flight on Takeover by AstraZenecaNASDAQ:ICVXIcosavax Inc
12/12/202302:02Dow Jones NewsAstraZeneca to Buy Icosavax for Up to $1.1 Billion -- UpdateNASDAQ:ICVXIcosavax Inc
12/12/202301:47Dow Jones NewsAstraZeneca to Buy Icosavax for Up to $1.1 BillionNASDAQ:ICVXIcosavax Inc
12/12/202301:05GlobeNewswire Inc.Icosavax, Inc. Announces Agreement to be Acquired by AstraZenecaNASDAQ:ICVXIcosavax Inc
12/12/202301:00GlobeNewswire Inc.Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older AdultsNASDAQ:ICVXIcosavax Inc
14/11/202315:05GlobeNewswire Inc.Icosavax Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ICVXIcosavax Inc
08/11/202307:00GlobeNewswire Inc.Icosavax to Participate in the Jefferies London Healthcare ConferenceNASDAQ:ICVXIcosavax Inc
31/10/202307:00GlobeNewswire Inc.Icosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) ConferenceNASDAQ:ICVXIcosavax Inc
19/09/202307:00GlobeNewswire Inc.Icosavax to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023NASDAQ:ICVXIcosavax Inc
14/08/202315:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICVXIcosavax Inc
14/08/202315:05GlobeNewswire Inc.Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ICVXIcosavax Inc
08/08/202315:05GlobeNewswire Inc.Icosavax Reports Positive 12-Month Durability Data for VLP Vaccine Candidate IVX-121 Against RSV and Initial Evidence for Revaccination PotentialNASDAQ:ICVXIcosavax Inc
25/07/202315:18Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ICVXIcosavax Inc
20/06/202307:00GlobeNewswire Inc.Icosavax Initiates Phase 2 Trial of IVX-A12 Against RSV and hMPV in Older AdultsNASDAQ:ICVXIcosavax Inc
14/06/202318:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ICVXIcosavax Inc
14/06/202318:41Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ICVXIcosavax Inc
 Showing the most relevant articles for your search:NASDAQ:ICVX

Su Consulta Reciente

NASDAQ
SVMH
SRIVARU
USOTC
KDDIF
KDDI (PK)
COIN
BICOETH
Biconomy Token
BTHB
STRATKRW
Stratis
BTHB
XLMKRW
Stellar Lumens
TSX
HSPN
Harvest Digital Sports a...
BIT
P1UE44
NLBNPIT1UE44 20991231 11...
USOTC
JWLLF
Jamieson Wellness (PK)
TG
DRH
DroneShield
COIN
FXSETH
Frax Share
COIN
PKRUST
POLKER
BOV
MRVE3Q
MRV ON
EU
UMI
Umicore
USOTC
JLGRF
Johns Lyng (PK)
COIN
WBPCUST
BuyPay
COIN
MNTLLUSD
Mantle
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados